Roger Seheult, MD of MedCram examines a new study comparing high dose Ivermectin, Fluvoxamine, and Metformin for outpatient COVID-19. See all Dr. Seheult's videos at: [ Ссылка ]
(This video was recorded on August 26, 2022)
Roger Seheult, MD is the co-founder and lead professor at [ Ссылка ]
He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine.
LINKS / REFERENCES:
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19 (NEJM) | [ Ссылка ]
Mission (Parsemus Foundation) | [ Ссылка ]
Prevention Protocol (FLCCC) | [ Ссылка ]
All coronavirus updates are at MedCram.com (including more discussion on delta variant covid, COVID Delta, COVID children, natural immunity COVID 19, and more).
MedCram Update 46: [ Ссылка ]
MedCram Update 47: [ Ссылка ]
MedCram Update 132: [ Ссылка ]
SUBSCRIBE TO THE MEDCRAM YOUTUBE CHANNEL:
[ Ссылка ]
Get notified of new videos by hitting the bell icon
MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS:
MedCram offers group discounts for students and medical programs, hospitals, and other institutions. Contact us at customers@medcram.com if you are interested.
MEDIA CONTACT:
Media Contact: customers@medcram.com
Media contact info: [ Ссылка ]
Video Produced by Kyle Allred
FOLLOW US ON SOCIAL MEDIA:
[ Ссылка ]
[ Ссылка ]
[ Ссылка ]
DISCLAIMER:
MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor.
#COVID19 #Omicron #Coronavirus
![](https://s2.save4k.ru/pic/5SeF67AaK74/maxresdefault.jpg)